Woodline Partners LP Grows Position in The Cooper Companies, Inc. $COO

Key Points

• Woodline Partners LP increased its stake in The Cooper Companies, Inc. by 0.9%, now owning approximately 0.28% of the company valued at $47.86 million.
• The Cooper Companies reported $1.10 EPS for the last quarter, surpassing estimates, with a year-over-year revenue growth of 5.7%.
• Analyst ratings for Cooper Companies show a mix of opinions, with a current average target price of $86.64 and most analysts assigning a "Moderate Buy" rating.

Woodline Partners LP raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 0.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 567,402 shares of the medical device company's stock after purchasing an additional 4,902 shares during the quarter. Woodline Partners LP owned 0.28% of Cooper Companies worth $47,860,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Zions Bancorporation National Association UT bought a new stake in shares of Cooper Companies during the first quarter worth $33,000. City Holding Co. bought a new stake in shares of Cooper Companies during the first quarter worth $34,000. GKV Capital Management Co. Inc. bought a new stake in shares of Cooper Companies during the first quarter worth $40,000. Larson Financial Group LLC lifted its position in shares of Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on COO shares. Robert W. Baird decreased their target price on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research report on Thursday, August 28th. UBS Group upgraded Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the company an "equal weight" rating in a report on Thursday, August 28th. Loop Capital set a $100.00 price objective on Cooper Companies in a report on Tuesday, June 17th. Finally, BNP Paribas upgraded Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $86.64.

Insider Activity at Cooper Companies

In related news, CEO Albert G. White III acquired 10,000 shares of the business's stock in a transaction dated Friday, September 5th. The shares were purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the acquisition, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. The trade was a 4.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Daniel G. Mcbride acquired 3,000 shares of the business's stock in a transaction dated Tuesday, September 2nd. The shares were bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the acquisition, the chief operating officer owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is owned by insiders.

Cooper Companies Stock Down 2.6%

COO traded down $1.78 on Friday, hitting $66.68. The company had a trading volume of 3,147,814 shares, compared to its average volume of 3,235,975. The stock has a fifty day moving average price of $71.53 and a 200-day moving average price of $75.90. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $112.38. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The stock has a market capitalization of $13.26 billion, a price-to-earnings ratio of 32.85, a P/E/G ratio of 1.80 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the previous year, the firm earned $0.96 earnings per share. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.